Rachael Joyner’s journey from learner to Duke clinician showcases the transformational impact of the Duke-UNC Tobacco Treatment Specialist Training Program.

In the last year, the U.S. Food and Drug Administration began publicly acknowledging harm reduction as a legitimate principle within its regulatory framework. Through its Premarket Tobacco Product Application process, companies can gain authorization to sell their products in the U.S. An important distinction here is that these products are not recognized by the FDA as being safe or approved for treatment of tobacco use disorder.

The Duke-UNC Tobacco Treatment Specialist Training Program is excited to announce the expansion of our free Essential Tobacco Treatment Toolkit—a comprehensive resource designed to improve access to evidence-based tobacco and nicotine dependence treatment. The updated toolkit now includes an even wider range of materials created to support both clinicians and individuals who want to quit tobacco.